October 17 – 19 2013 in Dublin, Ireland at the Convention Centre. The EAO’s Scientific Committee has prepared a programme that will address many practical and highly relevant issues of concern to both clinicians and patients and also highlight the real and emerging issues that arise in a population that is ageing and which has increasingly complex needs. Dublin is a very historic and exciting capital city. The medieval, Georgian and modern architecture provides an intriguing backdrop to this cosmopolitan city, famous for its musical, theatrical and literary traditions. You will have an opportunity to experience the many cultural activities and historic landmarks of the city and enjoy the extensive and varied opportunities for entertainment, good food and shopping. The congress will take place at the newly opened and internationally acclaimed Convention Centre Dublin situated on the river Liffey in the heart of the city with spectacular views across Dublin and its surroundings.
Reducing case complexity, increasing treatment predictability, and optimizing workflows are key topics for technology advancements. As an example, the development of intelligent synthetic materials and the opportunity for an improved control of the bone remodeling process and the subsequent substitution by newly formed bone may increase overall flexibility in everyday patient treatment. Bone substitutes evolve from being a purely incorporated filling and space maintaining material towards scaffolds effectively facilitating pristine bone regeneration. Early findings on a new bone substitute targeted to guide natural bone regrowth by using an innovative granule surface structure are an illustration for high-performance innovation by Straumann®. Clinical data on pioneering implant technologies such as the Roxolid® material and SLActive® hydrophilic surface clearly document the higher treatment predictability, increasing confidence in using small-diameter implants. Recent data further underline the benefits, particularly the potential for reducing treatment steps and greater treatment flexibility in limited bone volume. This allows for interesting considerations regarding reduced implant diameter and length, preserving more vital structures around the implant and reducing the need for invasive grafting procedures. There may be new ways of implant treatment, which may help to increase patient acceptance with enhanced prosthetic solutions.
What is the role of technology advancements to support new ways of implant treatment? What are the possibilities for increased treatment flexibility and patient acceptance, especially to increase the quality of life for elderly patients, arising from the availability of technology innovations? Where are the considerations and boundaries in every day practice? These questions will be addressed in the following topics from a bone regeneration, implantation and prosthetic point of view.